News (Archives 2011-2001 on CML ) - Chronic Myeloid Leukemia
Bloomington boy starts 2012 by realizing dream
December 31, 2011, Victoria advocate.com
Fish Oil Derivative Cures Cancer VIDEO
December 30, 2011, Doctor Saputo
For Phoenix woman, every day a blessing after cancer VIDEO
December 28, 2011, azcentral.com
With India in global network, stem cell transplant to get easier
December 28, 2011, The Times of India
Key Genetic Error Found In Family Of Blood Cancers
December 28, 2011,Medical News Today
For Phoenix woman, every day a blessing after cancer
December 28, 2011, Tucson Citizen
Fish Oil May Cure Leukemia
December 28, 2011, Diets in Review.com
Daughter giving New Smyrna dad gift of life
December 27, 2011, The Daytona Beach News-Journal
Promising Blood Cancer Treatments
December 26, 2011, MD India
Fish oil may help cure leukemia
December 24, 2011, The Hindu
Eva Schamp celebrates 10 years as cancer survivor
December 23, 2011, gazettetimes.com
Dr. Jorges Cortes: ASH2011 - Two New Winners for CML? VIDEO
December 23, 2011, Medscape News Today
Professor’s Research Supported by $331K NIH Grant
December 23, 2011, Umass Lowell
Fish oil may hold key to leukemia cure
December 22, 2011, MedivalXpress
Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice
December 22, 2011, Journal Blood
Powered Device Hailed as Advance for Bone Marrow Biopsy
December 22, 2011, Medscape News Today
Promising treatments for blood cancers presented by JTCancerCenter researchers at ASH meeting
December 22, 2011, EurekAlert
Many cancer cases, now manageable, although roadblocks remain
December 22, 2011, USA TODAY Your life
Ariad Pharmaceuticals Still Might Have Upside
December 21, 2011, Investor Place
ELN Recommendations - Patient-friendly summary in four languages
December 21, 2011, CML Advocates Network
Waging War Against Chronic Myeloid Leukemia
Chronic Myeloid Leukemia responds well to experimental drug ponatinib
December 20, 2011, DailyRX
Raising Awareness of Haematology in Europe
December 20, 2011. AdvocacyEHA
Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival
December 19, 2011, Journal Blood
The Apothecary Shops Incorporates Innovative Technology Into Patient Medication Reminders
December 19, 2011, PRNewswire
5 Winners Of American Society Of Hematology 2011
December 19, 2011, Seeking Alpha
Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells
December 19, 2011, Leukemia
YM's Positive Results Have Incyte Investors Worried
December 15, 2011, Seeking Alpha
FDA approves update for Tasigna label
December 15, 2011, Modern Medicine
ENEST: Patients with Ph+CML exhibited deeper responses to nilotinib than imatinib mesylate
December 15, 2011, HemoncToday
Study: Two Sisters Suffer From Lymphoma
December 15, 2011, Heal Blog (blog)
CML updatde from 2011 ASH annual meeting
December 14, 2011, Biotech Strategy Blog
Nilotinib shows promise as first-line therapy in CML
December 14, 2011, HemoncToday
Unlocking CML resistance -Tasigna plus MEK inhibitors overcomes Gleevec resistance
Dec 14, 2011, DailyRx
Food Dude: The Sweete Bye and Bye
December 14, 2011, NewOK.com
More news for ASH meeting
December 13, 2011, The Pharma Letter
Bio-Path Holdings' Initial Phase I Data in Leukemia Clinical Trial Demonstrates That Its Neutral Lipid Delivery Technology Antisense Drug BP-100-1.01 (Liposomal Grb-2) is Well Tolerated with Activity Seen at Low Starting Dose
December 13, 2011, BusinessWire
BELA Trial: Bosutinib May Be Superior to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
December 13, 2011, MPR
Society fulfills wishes of 11 children latest!
December 13, 2011, The Borneo Post
Two Novartis Phase III studies show twice as many Ph+ CML patients achieve deeper levels of response with Tasigna® compared to Glivec
December 12, 2011, Reuters
Study of 2 sisters sheds light on lymphoma evolution
December 12, 2011, EurekAlert
Onyx Trips, Ariad and Pharmacyclics Shine at Blood Cancer Meeting
December 12, 2011, The Street
CLAG in Combination with Imatinib Mesylate Shows Promise in Relapsed or Refractory Acute Myeloid Leukemia
December 12, 2011, MPR
Stemline Therapeutics, Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference
December 12, 2011, The Sacramento Bee
Ariad Cancer Drug Positive Trial May Boost Approval Chances
December 12, 2011, Bloomberg Businessweek
Pre-Market NASDAQ Movers (ENDP, BPAX, ARIA, ONXX, DMND, NUAN, ASML, CSCO)
December 12, 2011,International Business Time
HyperCVAD Plus Dasatinib Effective in Patients with Ph+ ALL or CML-LB
December 11, 2011, MPR
ASH: Bone Marrow Best for Unrelated Donor SCT
December 11, 2011,, Medpage Today
Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: Approach to Patients with Treatment-Naive or Refractory Chronic-Phase Disease
December 10, 2011, Hematology
Educational Session: Managing Chronic Myeloid Leukemia as a Chronic Disease
December 10, 2011, Hematology
Minimal Residual Disease and Discontinuation of Therapy in Chronic Myeloid Leukemia: Can We Aim at a Cure?
December 10, 2011, Hematology
Girl's Disney dream comes true
December 10, 2011, The Post and Courier
New method to destroy chronic myeloid leukemia cells discovered
December 10, 2011, Health Jockey
The Path of Science and Hope: Ph+ CML VIDEO
December 9, 2011, Novartis
Thorburn: Like home runs, singles can lead to wins against cancer mortality
December 9, 2011, Colorado Cancer blog
Scientists discover how to beat resistance to standard leukaemia drug
December 9, 2011, MedicalXPress
Scientists discover how to beat resistance to standard leukaemia drug
December 8, 2011, Cancer Research UK
NICE backs two Novartis CML drugs; BMS denied
December 7, 2011, PMLive
ASH Calls on Congress to Take Action to Prevent Drug Shortages
December 6, 2011, The American Society of Hematology
Nice has recommended Glivec, Tasigna for the first line treatment of CML
December 6, 2011, The National Institute for Health and Clinical Excellence (NICE)
NICE Backs Novartis' Glivec, Tasigna for CML, Rejects Sprycel
December 6, 2011, NASDAQ
Experts Question Benefits of High-Cost Cancer Care
December 5, 2011, Medscape News
When "personalized gene-targeted cancer therapy" really means "making it up as you go along"
December 5, 2011, ScienceBlogs
What's Hot at ASH 2011?
December 2, 2011, Medscape Today
Novartis highlights advances for patients with breast cancer and hematological diseases with over 160 SABCS and ASH abstracts
December 2, 2011, Reuters
Patients suffering from blood cancer: Khyber Pakhtunkhwa government launches Rs 7.2 billion free treatment project
December 2, 2011, Business Recorder
2011 ASH Annual Meeting to Highlight Latest Hematology Research, Clinical Care Breakthroughs
December 1, 2011, American Society of Hematology
Which is better for Chronic Myeloid Leukemia?
December 1, 2011, DailyRx
2011 ASH Annual Meeting to Highlight Latest Hematology Research, Clinical Care Breakthroughs
December 1, 2011, PRNewswire
National experts from the John Theurer Cancer Center will present 31 studies at the 2011 ASH Meeting
December 1, 2011, Physorg.com
New Method That Reveals Complete Set of Aberrant Signaling Pathways That Give Rise to Cancers
December 1, 2011, HealthNewsDigest.com
OTCtipReporter.com: OncoVista Innovative Therapies, Inc. (OTCBB: OVIT), Amwest Imaging Incorporated (OTCBB: AMWI), Umami Sustainable Seafood Inc. (OTCBB: UMAM): Sign up for our FREE Stock Picks Today!
November 30, 2011, TechZone360
Menthol Cigarettes Not Less Harmful, say Experts
November 29,2011, The Sacremento Bee
Depression in Blood Cancer Patients
November 28, 2011, About.com
Hematopoietic stem cells may explain why elderly more prone to leukemia and infections
November 28, 2011, DailyRX
New CML Health Education Center on Patient Power
November 27, 2011, Patient Power
Helping One of Their Own (Child with CML)
November 26, 2011, TheEveningSun
Expanding Chronic Myeloid Leukemia Treatment Options
November 26, 2011, dailyRX
Schusterman Caps Israel-to-Tulsa Oil Career With KKR Sale
November 25,2011, Bloomberg Businessweek
Wakeboarder battles Leukemia, but she 'lives strong' VIDEO
November 24, 2011, My Fox Orlando
A giving sacrifice - Her five year old son was diagnosed with CML just under two years ago
November 22, 2011, Leominster Champion
Chronic myeloid leukemia research focuses on genes and drug therapies
November 22, 2011, DailyRX
BIG Girls Care this Holiday Season
November 21, 2011, Trib Local BurrRidge/Willowbrook
Medical Resources: Understanding Leukemia
November 21, 2011, Online Nursing Degrees
Push is on to stay one step ahead of cancer
November 21, 2011, Boston.com
MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
November 21, 2011, Sacramento Bee
Canadian researchers find potential new leukemia treatment with old antibiotic drug
November 20. 2011, Canadian Biotechnologist 2.0
Oral chemo insurance legislation in works
November 19, 2011, Central Wisconsin hub
Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinib
November 18, 2011, Journal Blood
Lab Notes: Cancer Drug for TB?
November 18, 2011, Medpage Today
Kareem Abdul-Jabbar on being honored with Double Helix Medal, NBA lockoutNovember 17, 2011, CNNARIAD Announces Interim Safety and Efficacy Data from Pivotal Ponatinib PACE Trial to Be Presented at Annual American Society of Hematology Meeting
November 17, 2011, Business Wire
Finding Emotional Support for Long-term Illness
November 16, 2011, OncologyNurseAdvisor
Coaches for Cancer Tournament
November 16, 2011, abc4.com
How cancer has made me feel like the luckiest person around
November 15, 2011, Parenting Post
Donating marrow through the Be The Match Registry could save a life
November 15, 2011, Courier-Herald
Bobcats help lift leukemia-stricken fan
November 15, 2011, Bozeman Daily Chronicle
Laboratory honors NBA icon, researchers
November 15, 2011, Newsday
Signs, Symptoms and Definition of Leukemia
November 15, 2011, EmpowHer
Franchisee Battles New Storm against Pizza Hut
November 15, 2011, Blue Maumau
Pregnancy and a Cancer Diagnosis VIDEO
November 14, 2011, Patient Power
Florida Blood Center holding New Smyrna Beach blood/bone marrow drive
November 13, 2011, The Daytona Beach News-Journal
NBA star to talk about health, exercise
November 13, 2011, Indystar.com
Ariad falls as drug tied to side effects
November 13, 2011, The Boston Globe
Pfizer To Present Clinical Data From Its Hematology Portfolio At The 53rd Annual Meeting Of The American Society Of Hematology
November 13, 2011, PharmPro
Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results.
November 11, 2011, PubMed
Women, younger patients with CML at risk for decreased health-related quality of life
November 11, 2011, HemoncToday
Some drugs are Easier to Stick with Than Others - CML patients more likely to adhere to dasatinib than nilotinib
November 11, 2011, DailyRX
FDA Drug Safety Communication: Sprycel (dasatinib) and risk of pulmonary arterial hypertension
November 10, 2011, U.S. Food and Drug Administration
PGI to hold 3 day conference from Nov 10
November 10, 2011, Day & Night News
Kareem Abdul-Jabbar Cancer in remission
November 10, 2011, The Post Chronicle
CML Patients May Need Fewer Bone Marrow Biopsies in the Future VIDEO
November 10, 2011, Patient Power
Tamera Simonson: 19-year CML Survivor VIDEO
November 10, 2011, Patient Power
New Evidence for Taking Medication at the Right Dose VIDEO
November 10, 2011, Patient Power
National Caregiver Month recognizes and supports those helping care for loved ones
November 9, 2011, JSOnline
Curis Announces Appointment of Maurizio Voi, M.D. as Chief Medical and Chief Development Officer
November 9, 2011, BusinessWire
Karyopharm Therapeutics Announces Presentations by Seven Collaborators Showing Major Progress in Advancing Selective Inhibitors of Nuclear Export (SINE) for Hematologic Malignancies at American Society of Hematology (ASH) Meeting
November 8, 2011,PRNewswire
Mini-Transplants - Age no longer barrier to stem cell transplants for older patients
November 7, 2011, Seattle Cancer Care Alliance
Ariad Pharma: Early Efficacy, Safety of Leukemia Drug 'Striking'
November 7, 2011, The Street
10-Q: ARIAD PHARMACEUTICALS INC
November 7, 2011. Middle East North Africa Financial Network
Study Sheds Light on Persisting CML
November 2011, Volume 06:11, ClinicalOncology
Study Links Gene Mutations With MDS Morphology
November 2011,Volume 06:11, ClinicalOncology
Sharon Diane Moore
November 6, 2011, Livingston Daily
Changing lives one run at a time
November 6, 2011, Florida Today
Good adherence to imatinib therapy among patients with chronic myeloid leukemia-a single-center observational study.
November 3, 2011, CancerCancel
Dr. Ruben Mesa Joins 23andMe's Myeloproliferative Neoplasms Initiative as Scientific Advisor
November 3, 2011, PRNewswire
Imatinib has adverse effect on growth in children with chronic myeloid leukemia.
November 2, 2011, Pediatr Blood Cancer.
Third 2011-12 Winning Attitude Recipient Announced
November 2, 2011, Colorado Buffaloes
Clolar-Cytarabine Regimen Prior To Stem Cell Transplant May Be Effective And Safe In Older, High-Risk MDS Patients
November 2, 2011, The MDS Beacon
Gynecomastia during imatinib mesylate treatment for gastrointestinal stromal tumor
November 2, 2011,7th Space
Age No Longer Should be a Barrier to Stem Cell Transplantation for Older Patients with Blood Cancers
November 1, 2011, NewsWise
Transplant Protocol Benefits Elderly With Hematologic Cancers
November 1, 2011, The Oncology Report
Solution Supplier Expands Offerings
November 1, 2011 , GEN
Lea Morrison: A Winner on Many Levels
October 31, 2011, Boston Foundation for Sight
The Cancer Drug Dark Ages Are Coming to an End
October 31, 2011, Xconomy
Matchmaker: A Day for Bone Marrow Donors
October 28, 2011, BelmontPatch
Bristol-Myers 3Q profit rises 2 pct. as sales jump
October 27, 2011, The Associated Press
CML: live long and prosper
October 27, 2011, Journal Blood
The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors
October 27, 2011, Journal Blood
Novartis new drugs soar but 2,000 jobs to go
October 25, 2011, PharmaTimes
Acute Myeloid Leukemia Test Cleared By FDA
October 24, 2011, ThirdAge
Nurse, doctor see cancer from both side
October 24, 2011, CNN Health
Too much of a good thing, not so good
October 21, 2011, bclocalnews.com
Myelodysplasia gene mutation can aid diagnosis
October 21, 2011, OncologyNurseAdvisor
Leukemia still a threat despite years of treatment? Blame stem cells
October 20, 2011, City of Hope
Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies
October 20, 2011, Journal Blood
Changes in the dynamics of the excess mortality rate in chronic phase-chronic myeloid leukemia over 1990-2007: a population study
October 20, 2011, Journal Blood
New Smyrna man needs match for bone marrow transplant
October 20, 2011, The Daytona Beach New- Journal
Benzene Wrongful Death Lawsuit Results in $7.5M Verdict
October 18, 2011, AboutLawsuits.com
New cancer meds caught in insurance squeeze
October 14, 2011, MiamiHerald.com
Leukemia patient turns to social media to save his own life
October 13, 2011, The Takeaway
Imatinib is receptive to a collaboration
October 13, 2011, Journal Blood
Finding clues in our blood
October 12, 2011, northshoreoflongisland.com
ARIAD to Present at the 18th Annual Newsmakers in the Biotech Industry Conference
October 12, 2011, Business Wire
FDA: Increased PAH Risk Seen With Dasatinib
October 11, 2011, Internal Medicine News Digital Network
Keeping his faith: Fundraiser benefits area musician battling cancer
October 4, 2011, The Advertiser.com
Navigating the Net Wisely in a Health Crisis
October 3, 2011, New York Times
Leukemia stem cells are a lingering threat despite many years of treatment
October 3, 2011, City of Hope
CV drug shows promise as a leukemia treatment
October 3, 2011, OncologyNurseAdvisor
TIM-3 in Leukemia; Immune Response and Beyond
September 30, 2021, frontiers
Recent advances in the path toward the cure for chronic myeloid leukemia
September 30, 2011, NCBI
Will every patient be an "N-of-1" when it comes to cancer?
September 30, 2011, Medpage Today
Andrew Matheson, The Point After: Watsonville's comeback kid living life on the field while battling leukemia
September 30, 2011, Santa Cruz Sentinel
Rod's story, how the love of a father is moving mountains - children from Philippines
September 29, 2011, The Max Foundation
Research and Markets: Global Chronic Myeloid Leukemia Drug Pipeline Capsule - 2011
September 28, 2011, Bradenton.com
Benzene Leukemia Lawsuit Filed by Man Who Grew Up Near Oil Refinery
September 27, 2011, aboutlawsuits.com
Vaccine researchers find a possible new approach to overcoming leukemia
September 26, 2011, City of Hope
ARIAD continues to achieve endpoints in ponatinib follow-up
September 26, 2011, Proactive Investors
The National CML Society and NBA's all-time leading scorer team up against leukemia, one anniversary at a time
September 24, 2011, Las Vegas Review-Journal
Reflections on Advocacy: Making Our Voices Heard - NCMLS on Capitol Hill 9/20/11
September 23, 2011, The National CML Society
How International CML Day in India was celebrated
September 23, 2011, The Max Foundation
Studying blood cancers has helped unlock mysteries of disease, paved the way to better treatments
September 23, 2011, AnnArbor.com
CML Awareness Day and Joy Smith, MP
September 23, 2011, Digital Journal
CML - Pathways to Discovery - Dr. Janet D. Rowley VIDEO
September 22, 2011, NationalCMLSociety
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
September 22, 2011, Blood Journal
The CML Society Marks CML Awareness Day with Stepping Stone Ceremonies
September 22, 2011, Digital Journal
Annual Nobel Predictions Announced, but Forecasting Prizes Remains a Tricky Business
September 21, 2011, Scientific American
Spooky theory, leukemia drugs top Nobel tips: Thomson Reuters
September 21, 2011, Reuters
How Thai doctors are having success treating a common form of leukaemia
September 20, 2011, Bangkok Post
International CML Day – Health Corner
September 20,2011, ExpressIndia
Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment.
September 19, 2011, Journal Blood
Pat Shares Her Health Story And Her Life As A Two Time Cancer Survivor VIDEO
September 15, 2011, EmpowHER
Convocation keynote: Keep the excitement of research and patient care alive
September 15, 2011, University of Massachusetts Medical School
Making the Miraculous Happen
September 15, 2011, Sherdog
Brazilian Hair Treatment Comes Under F.D.A. Fire
September 14, 2011, New York Times
Abandoned premature baby now Iraqi vet who lost both legs, cancer survivor searches for real parents
September 13, 2011, Daily News
An Immune System Trained to Kill Cancer
September 13, 2011, The New York Times
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
September 12, 2011, The Journal of experimaqntal medicine
Cardiovascular drug may offer new treatment for some difficult types of leukemia
September 12, 2011, EurekAlert
Nilotinib vs. Imatinib: Development of BCR-ABL Mutations
September 2011’, Volume 06:09, Clinical Oncology
Novartis Must Not Win This Case
September 10, 2011,News Click
India’s drug ‘lifeline’ under threat
September 8, 2011, New Internationalist
Acute leukemia gene seemingly unfolded
September 8, 2011, HealthJockey.com
Nilotinib trumps imatinib in leukemia study
September 7, 2011, OncologyNurseAdvisor
Glivec case transferred to new apex court Bench
September 6, 2011, Business Line
Leukemia Predisposition Gene Discovered
September 5, 2011, Medical News Today
Cancer survivor fights disease through advocacy work
September 2, 2011, Coastweek.com
Modified Citrus Pectin Packs Powerful Immune Punch
September 1, 2011, The Wall Street Journal
Ottawa issues warning about leukemia drug
September 1, 2011, The Chronicle Herald
Genetic fault behind rare cancer uncovered
August 31, 2011, Cancer Research UK
Leukemia drug Sprycel linked to dangerous side effect
August 30, 2011, The Canadian Press
Bosutinib a potential second-line treatment for chronic-phase CML
August 30, 2011, Hemonc Today
Widnes leukaemia patient says trial treatment at Royal Liverpool Hospital changed her life
August 29, 2011, Wirralnews
Imatinib Mesylate (Gleevec) as Protein-tyrosine Kinase Inhibitor Elicits Smooth Muscle Relaxation in Isolated Human Prostatic Tissue.
August 26, 2011, PublMed.gov
Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice
August 25, 2011, Journal Blood
'Nail in the coffin' for rare leukaemia patients, says Borehamwood man
August 23, 2011, Borehamwood & Elstree Times
ENESTnd: Nilotinib superior to imatinib for response, disease-specific death in chronic-phase CML at 2 years
August 23, 2011, Hemonc today
Pfizer Announces European Medicines Agency Acceptance of Regulatory Submissions For Two Investigational Cancer Therapies
August 23, 2011, Vadvert.co.uk
Nilotinib Still Trumps Imatinib in Chronic CML
August 20, 2011,Medpage Today
New discount persuades NICE to back Novartis' Tasigna
August 18, 2011,InPharm
Leukaemia patients given hope by NHS drugs watchdog
August 18, 2011, The Telegraph
Expert Insights: CML Updates From Summer 2011
August 17, 2011, Medscape education
Bio-Path Holdings Reports Second Quarter 2011 Financial Results
August 15, 2011, Business Wire
Bonney Lake Mayor Steps Away from Civic Duties to Undergo Cancer Treatment
August 15, 2011,BonneyLake-SumnerPatch
Free medication for Blood Cancer at SCB
August 14, 2011, IBNLive
First Cohort Successfully Completed in Bio-Path Holdings' Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2 in Leukemia
August 11, 2011, The Wall Street Journal
China Medical receives SFDA approval for 2 diagnostic tests
August 11, 2011, Proactiveinvestors
'Serial killer' cells eradicate leukemia tumours
August 10, 2011, CTV.ca
New leukemia treatment exceeds 'wildest expectations'
August 10, 2011, MSNBC.com
Genetically Modified "Serial Killer" T Cells Obliterate Tumors in Patients with Chronic Lymphocytic Leukemia, Penn Researchers Report
August 10, 2011, Penn Medicine
Cepheid Announces Release of Updated Xpert BCR-ABL Monitor Test
August 9, 2011, The Sacremento Bee
Bcr-abl signals to desensitize chronic myeloid leukemia cells to interferon alpha via accelerating the degradation of its receptor
August 5, 2011, Journal Blood
Other Diseases, Age, and Disease Status May Predict Outcome In MDS Patients Undergoing Reduced-Intensity Transplantation
August 5, 2011, The MDS Beacon
Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia
August 3, 2011, Cold Spring Harbor Laboratory
How Do Tumors Grow?
August 2, 2011, Scientific American
Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line
August 2, 2011, 7th Space
ARIAD shares rise on EU review of potential cancer drug
August 1, 2011, Boston Business Journal
Funding veterinary medicine advances cancer treatments of human patients
July 29, 2011, OpenPR
NanoString Offers New Tool for Analyzing 25 Leukemia Fusion Genes in a Single Reaction
July 28, 2011, BusinessWire
Cancer can't hold back Minnesota wakeboarder VIDEO
July 27, 2011, Startribune.com
Scientists Integrate Single-Cell Processing and RT-qPCR for Parallel Analysis of Hundreds of Cells
July 27, 2011, GEN
NSAIDs associated with reduced risk for myeloid leukemias in adult women
July 26, 2011,Hemonctoday
Obesity and the risk of chronic myelogenous leukemia: is this another example of the neoplastic effects of increased body fat?
July 22, 2011, Leukemia
Canadians newly diagnosed with chronic myeloid leukemia now have new treatment option
July 22, 2011, CNW
A report from the front line of cancer treatment
July 20. 2011, io9.com
Is your car killing you with benzene?
July 19, 2011, American Cancer Society
John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting
July 18, 2011, Physorg.com
Optimizing the Selection of Kinase Inhibitors for Chronic Myeloid Leukemia Patients
July 15, 2011, Medscape News
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population
July 12, 2011, Journal Blood
Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia
July 1, 2011, European Respiratory Journal
Biomarker Predicts Worse Outcome in Chronic Myeloid Leukemia
July 11, 2011, The Oncology Report
Association of community cancer centers’ education project reveals most effective practices for treating CML patients in the community setting
July 11, 2011, Media Newswire
Patients Abandon Oral Chemotherapies Due to High Copays
July 2011, ClinicalOncology
One of the ‘’Easy Cancers’’
July 9, 2011, dailyRX
Man Claims Sunscreen Gave Him Leukemia
July 8, 2011, Courthouse News Service
Marker Found that Enables Segregation of True Human Hematopoietic Stem Cells from Multipotent Progenitors
July 8, 2011, GEN News
Found: the mother of all blood cells
July 7, 2011,NewScientist
The American Society of Hematology Honors Janet Rowley, MD, and Brian Druker, MD, with Ernest Beutler Lecture and Prize
July 7, 2011, Hematology.org
Worcestershire campaign to keep NHS leukaemia drug
July 5, 2011, News Hereford & Worcester
Transforming a diagnosis into inspiration
July 1, 2011, Las Vegas Review-Journal
Coventry Resident Attempts 100-Plus Mile Swim for Charity
July 1, 2001,CoventryPatch
Stopping Dasatinib and Nilotinib Explored in Chronic Myeloid Leukemia
June 30, 2011, Oncology Stat
Lincoln Leukaemia patient protests cancer funds withdrawal
June 30, 2011, Lincolnshire
Using the Web to understand your medical condition
June 29, 2011, Komonews.com
Inovio Pharmaceuticals' Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
June 29, 2011, PrNewswire
Tasigna receives Canadian approval
June 27, 2011, CNW
The Latest Weapon Against Cancer: Evolution
June 25, 2011, The Wall Street Journal
A message from a mending heart
June 25, 2011, Dayton Daily News
CML Patients Taking Imatinib Have Similar Mortality Rates to People in General Population - Pronostic
March 23, 2011, Journal of the National Cancer Institute
Bill Would Ensure Patient Access to Oral Chemotherapies
June 23, 2011, wgrz.com
Ph: not bad at all
June 22, 2011, Journal Blood
Evaluation of BCR-ABL monitoring in Chronic Myelogenous Leukemia in clinical practice VIDEO
June 21, 2011, OncUViewTV
Is There a Virus-Versus-Leukemia Effect?
June 21, 2011, CancerNetwork
Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML
June 21, 2011, Journal Blood
Imatinib sensitivity in BCR-ABL1-positive chronic myeloid leukemia cells is regulated by the remaining normal ABL1 allele
June 21, 2011, Cancer Research
Nilotinib Beats Imatinib at 24 Months in Treatment of CML
June 20, 2011, MedscapeToday
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
June 20, 2011, Journal of Clinical Oncology
Cancer survivors beat the odds, graduate high school VIDEO
June 20, 2011, MSNBC.com
Ariad Pharma - Ahead Of PACE
June 17, 2011, RTTNews
Race brings out the best in survivors
June 17, 2011, adn.com
Stopping CML therapies and eradicating CML: Patient perspective from EHA
June 15, 2011, CML Advocates Network
Faster Response Rates in CML with Bosutinib
June 15, 2011, MedscapeToday
The ghost of personalized medicine
June 14, 2011, The Scientist
Towards a more efficient therapy for a specific form of leukemia
June 14, 2011, AlphaGalileo
Webcasts of EHA Education Sessions are well worth watching
June 14, 2011, Biotech Strategy Blog
Treatment of chronic phase (CP) chronic myeloid leukemia (CML) patients who harbour the BCR-ABL T315I mutation with subcutaneous omacetaxine results in improved survival compared to historical data
June 12 2011, EHA 2011
Cessation of dasatinib or nilotinib therapy in chronic- phase chronic myeloid leukaemia patients with sustained complete molecular responses
June 12, 2011, EHA 2011
CML patients treated with TKI’s who obtain major molecular response are highly protected for transformation and this protection seems to be independent of the 18-month cutoff
June 11, 2011, EHA 2011
A molecular criteria have now been defined to guide decisions about if and when to use dasatinib or nilotinib VIDEO
June 11, 2011, ecancecr,tv
1 of the girls
June 9, 2011, dallasvoice.com
Leukaemia patients protest in Manchester at drugs threat
June 9, 2011, BBC - News Manchester
Cancer survivor: Tell people what you're going through
June 9, 2011, Rapid City Journal
Nilotinib Superior to Imatinib, Fewer Mutations in Treatment of CML-CP
June 6, 2011, Monthly Prescribing Reference
Improved survival in chronic myeloid leukemia (CML) since introduction of imatinib therapy: A single-institution experience in 1,570 patients referred within 1 month from diagnosis
June 6, 2011, ASCO 2011
A new symptom measure in chronic myeloid leukemia
June 6, 2011, ASCO 2011
Not his best time, but 'best' race for veteran runner
June 5, 2011, Sign on San Diego
Bosutinib Achieves Faster Response Rates in Newly Diagnosed Chronic Phase CML Patients Than Imatinib
June 3 , 2011, Monthly Prescribing Reference
Dasatinib Shows Superior Efficacy and Acceptable Tolerability, Supporting First-Line Use in Newly Diagnosed CML-CP
June 3 , 2011, Monthly Prescribing Reference
Leukemia drug tied to impaired growth in kids
June 2, 2011, Caring4Cancer
A Triumph in the War Against Cancer
May 2011, Smithsonian magazine
What can nurses do to help cancer survivors?
May 31, 2011, NursingTimes.com
Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis
May 31, 2011, PubLmed
Reframing our thinking about cancer
May 26, 2011, Benefits Canada
Developer of Gleevec sees potential for more cancer drugs, will speak at Moffitt Cancer Center
May 26, 2011, tampabay.com
New Protein Linked to Alzheimer's Disease
May 25, 2011, Science Daily
Understanding Targeted Treatments
May 25, 2011, Cancer.net
Children’s Hospital Los Angeles Team Discovers Key to Fighting Drug-Resistant Leukemia
May 18, 2011, Enhanced Online News
Improved Survival And Treatment For Chronic Blood Disorders
May 18, 2011, Medical News Today
New approach to overcoming TKI resistance
May 18, 2001, ecancermedicalnews
Low incidence rate of opportunistic and viral infections during imatinib
treatment in chronic myeloid leukemia patients in early and late chronic phase
May 16, 2011, Mediterranean Journal of Hematology and Infectious diseases
Study Reveals Origins of a Cancer Affecting the Blood And Bone Marrow
May 12, 2011, Insciences organisation
Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase
May 11, 2011, ScienceDirect
Bcr-Abl Kinase Domain Mutation Analysis in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inihibitors: Recommendations From an Expert Panel on Behalf of European LeukemiaNet
May 11, 2011, Oncology Stat
Oregon Health & Science University celebrates 10th anniversary of cancer drug Gleevec
May 10, 2011, OregonLive.com
High Dose Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients - Systematic Review and Meta-Analysis
May 9, 2011, Oncology Stat
NICE provisionally rejects leukaemia drugs Sprycel, Tasigna and Glivec
May 6, 2011, Firstword
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
May 5, 2011, Journal of Clinical Oncology
The soul of a cell: Researchers used advanced instrument to read cells' minds
May 5, 2011, Stanford School of Medicine
ARIAD Reports First Quarter 2011 Financial Results and Development Progress
May 4, 2011, Enhanced Online News
A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia.
May 3, 2011, Unbound Medline
CML patients’ dilemma
May 2, 2009, The Star Online
Predicting Complete Cytogenetic Response and Subsequent Progression-Free Survival in 2060 Patients With CML on Imatinib Treatment: The EUTOS Score
May 2, 2011, OncologyStat
Day in the Life: OHSU's Brian Druker
April 29, 2011, Portland Business Journal
US Appeals Court Opens Federal Funding for Stem Cell Research
April 29, 2011, ScienceDaily
Nonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia
April 27, 2011, Wiley Online Library
Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet
April 24, 2011, Journal Blood
A Model of Oscillatory Blood Cell Counts in Chronic Myelogenous Leukaemia.
April 22, 2011, Springerlink.com
An Oncologist's Pulitzer-Winning Cancer Biography
April 22, 2011, Wbur.org
Does Pretreatment Fluorescence In Situ Hybridization for BCR–ABL Predict Imatinib-Associated Hematologic Toxicity in Chronic Myeloid Leukemia?
April 20, 2011, OncologyStat
Decoding Cancer Patients' Genomes Is Powerful Diagnostic Tool
April 20, 2011, ScienceDaily
Considerations in the Management of Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy
April 20, 2011,Journal of Clinical Oncology
The ABL Switch Control Inhibitor DCC-2036 Is Active against the Chronic Myeloid Leukemia Mutant BCR-ABLT315I and Exhibits a Narrow Resistance Profile
April 19, 2011, Unbound Medline
Updates of New Strategies in Chronic Myelogenous Leukemia
Spring 2011, Leukemia Insights, MD Anderson Cancer Center
A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia
April 14, 2011,Blood Journal
A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia
April 14 2011, Journal Blood
Study: Revolutionary Treatment Returns Normal Life Expectancy to CML Patients
April 12, 2011, EmpowHer
New drug shows potential for treatment-resistant leukemia
April 11, 2011, Pharmalive
Third Rock’s biggest bet ever is on cancer drugs
April 11, 2011, boston.com
Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
April 10, 2011, Journal Blood
ARIAD Presents New Preclinical Data On Ponatinib In Solid Tumors, Demonstrating Inhibition Of All FGF Receptor Kinases
April 6, 2011, Medical News Today
A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
April 1, 2011, PubLmed
The 2011 Stanley J. Korsmeyer Award
April 1, 2011, The American Society for Clinical Investigation
Potential Treatment For Chemotherapy-Resistant Chronic Myeloid Leukaemia
March 31, 2011, Medical News Today
Study Reveals No Impact of Age on Outcome in Chronic Myeloid Leukemia Patients Treated With Imatinib
March 30,2011, The American Society of Hematology (ASH)
New approach to leukemia chemotherapy -- is a cure in sight?
March 30, 2011, ScienceDaily
ARIAD And MolecularMD Announce Collaboration for a Companion Diagnostic Test for The T315I BCR-ABL Mutation in Patients With CML
March 28, 2011, Business Wire
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation
March 25, 2011, PublMed
Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML
March 25, 2011, Wiley online Library
CML Patients Taking Imatinib Have Similar Mortality Rates To People In General Population
March 22, 2011, JNCI Journal of the National Cancer Institute
Leukemia Patients Taking Gleevec Achieve ‘Normal’ Death Rate
March 22, 2011, HealthDay News
Gleevec Gets High Marks for Leukemia Treatment
March 22, 2011, WebMD
Imatinib for Chronic Myeloid Leukemia: The Impact of Its Effectiveness and Long-term Side Effects
March 21, 2011, JNCI Journal of the National Cancer InstituteBone Marrow Transplant Centres Alerted To Help
Japan Radiation Victims
March 16, 2011, Medical News Today
Second-Line TKIs Offer Expanded Treatment Options For Newly Diagnosed Patients With CML
March 14, 2011, Medical News Today
Can grapefruit juice decrease the cost of imatinib for the treatment of chronic myelogenous leukemia?
March 7, 2011, Leukemia Research
Discontinuation of imatinib may be possible in chronic myelogenous leukemia
March 3, 2011, Cancer Journal for Clinicians
FDA Warns GERD Drugs May Deplete Magnesium
March 2, 2011, Medpage Today
Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapy;
February 28, 2011, Haematologica
Second-generation drugs called into first-line therapy for CML
February 25, 2011, Hemonctoday
Survival of chronic myeloid leukemia stem cells is independent of BCR-ABL tyrosine kinase activity
February 23, 2011, Oregon Health & Science University (OSHU)
The renaissance of interferon therapy for the treatment of myeloid malignancies
February 22, 2011, Journal Blood
Changing the paradigm in frontline CML therapy VIDEO
Prof Giuseppe Saglio - University of Turin, Italy;
Dr Delphine Rea - Saint Louis Hospital, Paris;
Jan Geissler - Co-Founder, CML Advocates Network
February 21, 2011, ecancer.tv
What`s new in chronic myeloid leukemia research and treatment?
February 17, 2011, American cancer Society
Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study
February 2011, PublMed
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib
February 8, 2011, JNCI Journal of the National Cancer Institute
A single-tube allele specific-polymerase chain reaction to detect T315I resistant mutation in chronic myeloid leukemia patients
February 8, 2011,7th Space Interactive
The Matriarch of Modern Cancer Genetics
February 7, 2011, The New York Times
Clinical value of assessing the response to imatinib monitored by interphase FISH and RQ-PCR for BCR-ABL in peripheral blood for long-term survival of chronic phase CML patients: results of the Niigata CML-multi-institutional co-operative clinical study.
February 5, 2011, PublMed
Scientists reprogram marrow cells from patient with chronic myeloid leukemia
February 4, 2011, The Medicals News
Hematology: Curing CML with imatinib—a dream come true?
February 1, 2011, Nature Reviews Clinical Oncology
World Cancer Day 2011 - A World without Cancer One Day?
February 2011, Dr. Toh Han Chong, National Cancer Center, Singapore
Southampton scientists begin patient trials of new leukemia cancer vaccine
January 31, 2011, Physorg.com
University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
January 31,2011, PharmaLive
Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors.
January 26, 2011, PubLMed
Bosutinib as a treatment for newly diagnosed chronic myeloid leukaemia VIDEO
February 18, 2011, ecancerTV
Fertility in Women Diagnosed with Chronic Myeloid Leukemia
January 18, 2011, Preservation of fertility
Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?
January 17, 2011, Unbound Medline
Cancer: Should we stop trying to cure it?
January 15, 2011, Guardian.co.uk
Effects of imatinib mesylate on the pharmacokinetics of paracetamol (acetaminophen) in Korean patients with chronic myelogenous leukaemia
January 10, 2011, Wiley Online Library
Blood test to spot cancer gets big boost from J&J
January 5,2011, USA.TODAY.com
Time-specific blockade of PDGFR with Imatinib (Glivec) causes cataract and disruption of lens fiber cells in neonatal mice.
December 27, 2010, BipPortfolio
Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
December 23, 2010, The New England Journal of Medicine
Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy.
December 22, 2010, Unbound Medline
Cancer Cells May Be Able to Urge Their Own Death
December 22, 2010, CancerCompass
ASH 2010 Report: A new era in first line CML treatment coming up?
December 15, 2010, CML Advocates Network
Vital Discovery in Leukemia Stem Cell
December 15, 2010, Med India
Chronic Myeloid Leukemia: New Approaches Needed
December 15, 2010, MedicalNewsToday
Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system.
December 15, 2010, CMLHope.com
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
December 13, 2010, The Journal of Clinical Investigation
BCR-ABL kinase is dead; long live the CML stem cell
December 13, 2010, The Journal of Clinical Investigation
Zen Meditation Can Help Bring Pain Under Control
December 10, 2010, HealthDay news
Treatment of the elderly population with haematological cancers: What's new from the American Society of Hematology 2010 meeting?
December 8, 2010, ecancermedicalscience
Industry update: Bosutinib produces molecular response as first-line CML therapy
December 8, 2010, CancerNetwork.com
Deeper molecular responses seen with dasatinib in new chronic myeloid leukemia
December 7, 2010, CancerNetwork.net
Dasatinib moves ahead of imatinib as front-line therapy for newly diagnosed CML in chronic phase
December 7, 2010, CancerNetwork.com
Nilotinib exerts positive effect in early chronic phase Ph+ CML
December 7, 2010, CancerNetwork.com
ASH meeting: Pfizer’s bosutinib disappoints in myeloid leukemia trial; Novartis’ Tasigna beats Glivec in CML study
December 7, 2010, Thepharmaletter
ASH: New CML Drug Still Beating Out Its Predecessor
December 7, 2010, Medpage Today
Persistence of BCR-ABL-Expressing leukemic stem cells in chronic myeloid leukemia (CML) patients in complete remission with undetectable molecular disease
December 7, 2010, ASH 2010
Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy
December 6, 2010, Haematologica
Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia
December 6, 2010, Digital Journal
Compound Bosutinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia
December 6, 2010, Dagorret
ASH: Early assessment of molecular response identified increased risk for treatment failure in CML
December 6, 2010, Hemonctoday
Novel CML Drug Active After Failures of Imatinib, Dasatinib, and Nilotinib
December 6, 2010, Oncology Stat
ASH 2010: JAK2-Mediated Extrinsic Survival of CML Stem Cells: Exploring the Potential Combination of BCR-ABL and JAK2 Inhibitors In Vivo
December 6, 2010, ASH2010
Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia
December 5, 2010, ASH2010
ASH 2010: Ponatinib for refractory chronic myelogenous leukaemia
December 4, 2010, EcancerMedicalScience
ASH 2010: Nilotinib promising for early chronic phase, Philidelphia-positive chronic myeloid leukaemia
December 4, 2010, Ecancermedicalscience
Pfizer Plans Regulatory Submissions Of Bosutinib In Chronic Myeloid Leukemia
December 4, 2010, Medical NewsToday
Nilotinib associated with stable outcomes in Ph+CML
December 4, 2010, Hemonctoday
Breakthrough Therapies and a New Gene Target Advance the Treatment and Understanding of Hard-to-Treat Leukemias
December 4, 2010, Hematology.org
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
December 4, 2010, Hematology
Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase
December 2, 2010, Dovepress
Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
November 29, 2010, PubLMed
CML—The Changing Landscape of Front-line Therapy: Part I: Interview With Dr. Jane Apperley
November 23, 2010, OncologyStat - CMLSupport
Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia
November 20, 2010, PubMed
Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia
November 19, 2010, Leukemia
Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission
November 18, 2010, BMC Blood Disorders
Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms
November 16, 2010, SciElO Brazil
Mutated Gene Linked to Poor Survival in Acute Myeloid Leukemia
November 16, 2010, National Cancer Institute
Nilotinib Attenuates Renal Injury and Prolongs Survival in Chronic Kidney Disease
November 13, 2010, JASN
Low Vitamin D Linked to Deterioration in Certain Leukemia Patients
November 12, 2010, MedecineNet.com
Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemia.
November 9, 2010, PubLMed
Leukemia breakthrough suggested in lab finding
November 7, 2010, Globe and Mail
Canadian researchers transform skin into blood
November 7,2010, National Post
FDA Approves SPRYCEL (dasatinib) as Treatment for Adult Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia
October 28, 2010,FierceBiotech
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR.
October 24, 2010,PubLMed
Nurse Practitioner Carolyn Blasdel – Montreal – August 2010 VIDEO
October 2010, CML Society of Canada
Dr. Georges Mathé, Transplant Pioneer, Dies at 88
October 2010, New York Times
CML: The Current Landscape - an interview with Dr. Jorge Cortes VIDEO
October 2010, The National CML Society (US)
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
October 2010, The Lancet Oncology, Early Online Publication
Some With Once-Deadly Leukemia Can Take a Break From GleevecSmall minority of CML patients went off the drug for 2 years with no sign of recurrence
October 2010, Healthday, U.S. News
CML Society of Canada - CML Awareness Day celebrates great progress against blood cancer but much more needed to ensure best outcomes for Canadian patients
September 2010, CNW Group
Philadelphia chromosome’ led to breakthrough in cancer treatment
September 2010, Philadelphia Business Journal
Do we have to kill the last CML cell?
September 2010, Nature.com
Dr. Sawyers on Outsmarting Cancer VIDEO
Dr. Charles Sawyers tells Katie Couric about the difficulties in treating different kinds of cancers, and importance of drug cocktails
September 2010, CBSNEWS.com
50th Anniversary of the Discovery of the Philadelphia Chromosome
September 28, 2010, WorldNews
Leukemia Types, Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML)
10 sept 2010, Healthcommunities.com
Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia.
September 2010, ResearchGate
Technique to Preserve Fertility in Young Women May Be Unsafe for Patients With Leukemia
August 16, 2010, Science Daily
Living with chronic myeloid leukemia VIDEO
Chronic myeloid leukemia, or CML, was once considered a death sentence but new treatment options have turned CML into a chronic, yet manageable disease for most patients.
August 2010,Info4YourLife
Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib
August 2010, Journal Blood
A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib
August 2010, Leukemia Research
Dasatinib, an immunomodulator?
August 2010, Journal Blood
New lab test could identify imatinib resistance
July 2010, Sciences News
Protein That Predicts Prognosis of Leukemia Patients May Also Be a Therapeutic Target
July 10, 2010, Science Daily
Chronic myeloid leukemia: mechanisms of blastic transformation
July 1, 2010, The Journal of Clinical Investigation
Major Molecular Response in CML Patients Treated with Tyrosine Kinase Inhibitors: The Paradigm for Monitoring Targeted Cancer Therapy
June 21, 2010, The Oncologist
Novartis gets US FDA approval for new Tasigna indication; agency panel backs HRA Pharma's ulipristal
June 18, 2010, Thepharmaletter
Cord blood transplants a viable option in leukemia
June 15, 2010, Reuters
The 'Dandelion' problem: IFN-a, imatinib and reactivation of dormancy
June 15, 2010, ecancernews
Newer Drugs Improve Upon Gleevec for Chronic Myeloid Leukemia VIDEO
June 04, 2010, MD Anderson Cancer Center
Update on Tyrosine Kinase Inhibitor Therapy for Chronic ...
June 2010, ASHP Advantage
Remission During Chronic Phase CML: Watching for Relapse
May 19, 2010, WebMD
Benefits of Banking Cord Blood
May 10, 2010, Suite101
PCR Confusion – A CML Patient’s Perspective
May 18, 2010, Cancernetwork.com
Differing age patterns in chronic myeloid leukemia by racial ethnic group.
May 2010, Journal of Clinical Oncology
South Korean firm develops drug to kill leukemia stem cells
April 22, 2010, BioSpectrum
Combination of simvastatin and imatinib sensitizes the CD34+ cells in K562 to cell death
March 31, 2010, Mendeley
BioSante announce positive data from GVAX leukemia vaccine in CML
March 2010, Pharma Strategy Blog
High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study.
February 2010, PubLMed
Living With a Formerly Fatal Blood Cancer
January 2010, The New York Times
Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy
January 9, 2010,
Hindawi Publishing CorporationPrevalence of Large Granular Lymphocyte Proliferation in Chronic Myeloid Leukemia (CML) Patients Treated with Dasatinib
December 5, 2009, ASH 2009
Individual Telomere Lengths in Chronic Myeloid Leukemia
November 2009, Neoplasia
Adelaide researchers on road to myeloid leukemia cure
October 2009, NEWS.COM.AU
Emergence of Chronic Myelogenous Leukemia From a Background of Myeloproliferative Disorder: JAK2V617F as a Potential Risk Factor for BCR-ABL Translocation
October 2009, Clinical Lymphoma, Myeloma & Leukemia
Update of recent studies in chronic myeloid leukemia
June 26, 2009, Journal of hematology & oncology
A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment
June 2009, Wiley Online Library
Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
May 28, 2009, Leukemia
Stanford researchers harness nanoparticles to track cancer cell changes
April 14, 2009, Stanford School of Medicine
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy
March 2009, Blood Journal
Data suggesting that omacetaxine can eradicate leukemic stem cells may offer a breakthrough for CML
March 26, 2009, eurekalert.org
Scientists Identify Molecular Signature for Leukemia Stem Cells
March 10, 2009, e! Science News
Scientists uncover indicator that warns leukemia is progressing to more dangerous form
February 17,2009, e! Science News
Artificial Human Bone Marrow Created In A Test Tube
December 22, 2008, Science Daily
Translation of the Philadelphia chromosome into therapy for CML
December 15, 2008, Journal Blood
Cancer drugs may treat type 1 diabetes
November 11, 2008, Bio-Medecine
New Stanford diagnostic test for rare leukemia appears to give faster results, study finds
October 6, 2008, Stanford School of Medicine
Targeted therapies for CML: practical considerations and comparisons
August 10, 2008, HemOncToday
The role of interferon-alpha in the treatment of chronic myeloid leukemia
August 20, 2007, PubMed
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia
June 12, 2007, The Journal of Clinical Investigation
Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance
June 2007, NCBI
Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib
March 2006, Journal of Clinical Oncology
Hypertriglyceridemia may be severe in CML patients treated with interferon-α
July 11, 2006, Wiley Online Library
Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib
March 2006, Journal of Clinical Oncology
Indications for Imatinib Mesylate Therapy and Clinical Management
March 4, 2004, The Oncologist
Quantitative Polymerase Chain Reaction Monitoring of BCR-ABL during Therapy with Imatinib Mesylate (STI571; Gleevec) in Chronic-Phase Chronic Myelogenous Leukemia
January 9, 2003, Clinical cancer research
Powerful Anti-Cancer Drug Emerges from Basic Biology
May 8, 2001, The New York Times
